- Home
- » Tags
- » Perospirone
Top View
- A Systematic Review of Combination and Volume 1, Issue 1B High-Dose Atypical Antipsychotic Therapy December 2011 in Patients with Schizophrenia
- 548 Trimipramine for Refractory Panic Attacks
- Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
- A Phase II Randomized, Double-Blind Placebo Controlled, Study Of
- Differential Effects of Subchronic Treatments with Atypical Antipsychotic Drugs on Dopamine D2 and Serotonin 5- Title HT2A Receptors in the Rat Brain
- (12) United States Patent (10) Patent No.: US 9.486.453 B2 Javitt (45) Date of Patent: Nov
- National Institute for Health and Care Excellence Surveillance Programme
- Drug Class Review on Atypical Antipsychotic Drugs
- 1 Proposal for Drug Coding of “List of Drugs to Be Prescribed with Special
- The Pharmacokinetics of Mianserin Suppositories for Rectal
- Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
- Evaluation of Perospirone (SM-9018), a Novel Serotonin-2 and Dopamine
- Neurobiological Bases of Quetiapine Antidepresant Effect in the Bipolar Disorder
- Letters to the Editor
- Drug Class Review Atypical Antipsychotic Drugs
- 2016.04 Atypical Antipsychotic Agents Drug Class Review.Pdf
- Pharmacogenetics of Antidepressants and Antipsychotics
- Thirty Years of Scientific Research on Second-Generation Antipsychotic Drugs in Japan: a Bibliometric Analysis*
- Antipsychotic Drugs Which Elicit Little Or No Parkinsonism Bind More Loosely
- Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
- Neuroscience Based Nomenclature - Nbn Glossary*
- Historical Overview of Psychoactive Mushrooms
- ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
- Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus
- Perospirone, a Novel Antipsychotic Drug, Inhibits Marble-Burying Behavior Via 5-HT1A Receptor in Mice: Implications for Obsessive-Compulsive Disorder
- A Pharmaco-EEG Study on Antipsychotic Drugs in Healthy Volunteers
- Summary of Investigation Results Antipsychotic Agents, Etc
- Antipsychotics What’S New?
- A61p25/06 (2006.01) A61p25/22 (2006.01)
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- The Opposite Effects of Fluvoxamine and Sertraline in the Treatment Of
- Long-Term Perospirone Treatment with a Single Dose at Bedtime in Schizophrenia : Relevant to Intermittent Dopamine D2 Title Receptor Antagonism
- Second-Generation Antipsychotic Drugs for Children and Adolescents
- Drug Repositioning Predictions by Non-Negative Matrix Tri-Factorization of Integrated Association Data
- Long-Term Efficacy and Tolerability of Perospirone for Young Help-Seeking People at Clinical High Risk: a Preliminary Open Trial
- A Functional Variant in the Serotonin Receptor 7 Gene (HTR7), Rs7905446, Is Associated with Good Response to Ssris in Bipolar and Unipolar Depression
- Serotoninergic Mechanisms in the Treatment of Obsessive–Compulsive
- A Critical Review of the Pharmacology and Clinical Effects of Current and Future Therapeutic Agents
- Safe and Effective Use of Psychotropic Drugs
- Systematized Survey on the History of Drug Discovery with Technical Development 2
- A Bibliometric Study of Scientific Research Conducted on Second-Generation Antipsychotic Drugs in Singapore
- Quetiapine for Insomnia: a Review of the Literature Sarah L
- Ylated (52) U.S